Thought Leader Interview: Bart Vannieuwenhuyse, Senior Director Health Information Sciences, Janssen Pharmaceutica; Coordinator EMIF
4th EMA-EBE joint Regulatory Policy Seminar: Emerging Medicinal Products – from Laboratory to Patient use
Interview with Keith Thompson, CEO of the UK Cell Therapy Catapult: Advanced therapies stand poised to change the drug discovery and development paradigm
Views from Eduardo Bravo of TiGenix: Allogeneic stem cell therapy makes a breakthrough in the clinic and is poised to address unmet medical need
Interview with Emil Pot, co-founder of ActoGeniX: Europe needs larger investment funds to create a funding escalator from phase II to phase III
Report from the Alliance for Regenerative Medicine (ARM) Investor Day in London: As cell and gene therapies turn in positive clinical data, attention turns to delivery to patients
Press Release: Better Science, Better Health Conference to Promote International Collaboration to Accelerate New Models in Healthcare
Press Release: Healthcare Consultancy Vital Transformation Expands to United States with Opening of Washington D.C. Office
Interview: Get Real – Using real world data for decision-making in R&D and health technology assessment
